These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Future of circulating tumor cells in the melanoma clinical and research laboratory settings. De Souza LM; Robertson BM; Robertson GP Cancer Lett; 2017 Apr; 392():60-70. PubMed ID: 28163189 [TBL] [Abstract][Full Text] [Related]
43. Detection of circulating tumor cells and evaluation of epithelial-mesenchymal transition patterns of circulating tumor cells in ovarian cancer. Jie XX; Zhang M; Du M; Cai QQ; Cong Q; Xu CJ; Zhang XY Transl Cancer Res; 2022 Aug; 11(8):2636-2646. PubMed ID: 36093536 [TBL] [Abstract][Full Text] [Related]
44. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice. Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364 [TBL] [Abstract][Full Text] [Related]
45. Epithelial-Mesenchymal-Transition-Like Circulating Tumor Cell-Associated White Blood Cell Clusters as a Prognostic Biomarker in HR-Positive/HER2-Negative Metastatic Breast Cancer. Guan X; Li C; Li Y; Wang J; Yi Z; Liu B; Chen H; Xu J; Qian H; Xu B; Ma F Front Oncol; 2021; 11():602222. PubMed ID: 34150608 [TBL] [Abstract][Full Text] [Related]
46. HER2 expression on tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancer. Nanou A; Zeune LL; Bidard FC; Pierga JY; Terstappen LWMM Breast Cancer Res; 2020 Aug; 22(1):86. PubMed ID: 32787900 [TBL] [Abstract][Full Text] [Related]
47. Phenotypic Heterogeneity and Metastasis of Breast Cancer Cells. Hapach LA; Carey SP; Schwager SC; Taufalele PV; Wang W; Mosier JA; Ortiz-Otero N; McArdle TJ; Goldblatt ZE; Lampi MC; Bordeleau F; Marshall JR; Richardson IM; Li J; King MR; Reinhart-King CA Cancer Res; 2021 Jul; 81(13):3649-3663. PubMed ID: 33975882 [TBL] [Abstract][Full Text] [Related]
48. The liver metastatic niche: modelling the extracellular matrix in metastasis. Drew J; Machesky LM Dis Model Mech; 2021 Apr; 14(4):. PubMed ID: 33973625 [TBL] [Abstract][Full Text] [Related]
49. Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer. Zhao R; Cai Z; Li S; Cheng Y; Gao H; Liu F; Wu S; Liu S; Dong Y; Zheng L; Zhang W; Wu X; Yao X Oncotarget; 2017 Feb; 8(6):9293-9302. PubMed ID: 28030836 [TBL] [Abstract][Full Text] [Related]
50. PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling. Sprouse ML; Welte T; Boral D; Liu HN; Yin W; Vishnoi M; Goswami-Sewell D; Li L; Pei G; Jia P; Glitza-Oliva IC; Marchetti D Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003475 [TBL] [Abstract][Full Text] [Related]
51. Fluid Shear Stress Induces EMT of Circulating Tumor Cells via JNK Signaling in Favor of Their Survival during Hematogenous Dissemination. Xin Y; Li K; Yang M; Tan Y Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143160 [TBL] [Abstract][Full Text] [Related]
52. Sequential Isolation and Characterization of Single CTCs and Large CTC Clusters in Metastatic Colorectal Cancer Patients. Francescangeli F; Magri V; De Angelis ML; De Renzi G; Gandini O; Zeuner A; Gazzaniga P; Nicolazzo C Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944983 [TBL] [Abstract][Full Text] [Related]
53. Heterotypic clustering of circulating tumor cells and circulating cancer-associated fibroblasts facilitates breast cancer metastasis. Sharma U; Medina-Saenz K; Miller PC; Troness B; Spartz A; Sandoval-Leon A; Parke DN; Seagroves TN; Lippman ME; El-Ashry D Breast Cancer Res Treat; 2021 Aug; 189(1):63-80. PubMed ID: 34216317 [TBL] [Abstract][Full Text] [Related]
55. S-Nitrosocaptopril prevents cancer metastasis in vivo by creating the hostile bloodstream microenvironment against circulating tumor cells. Lu Y; Lian S; Ye Y; Yu T; Liang H; Cheng Y; Xie J; Zhu Y; Xie X; Yu S; Gao Y; Jia L Pharmacol Res; 2019 Jan; 139():535-549. PubMed ID: 30366102 [TBL] [Abstract][Full Text] [Related]
56. Circulating Tumor Cells (CTCs) Heterogeneity in Metastatic Breast Cancer: Different Approaches for Different Needs. Vismara M; Reduzzi C; Daidone MG; Cappelletti V Adv Exp Med Biol; 2020; 1220():81-91. PubMed ID: 32304081 [TBL] [Abstract][Full Text] [Related]
57. Advances in the Characterization of Circulating Tumor Cells in Metastatic Breast Cancer: Single Cell Analyses and Interactions, and Patient-Derived Models for Drug Testing. Kujur PK; Flores BCT; Ramalingam N; Chinen LTD; Jeffrey SS Adv Exp Med Biol; 2020; 1220():61-80. PubMed ID: 32304080 [TBL] [Abstract][Full Text] [Related]
58. Epithelial-mesenchymal plasticity in circulating tumor cells. Alix-Panabières C; Mader S; Pantel K J Mol Med (Berl); 2017 Feb; 95(2):133-142. PubMed ID: 28013389 [TBL] [Abstract][Full Text] [Related]
59. Circulating Tumor Cell Clusters: United We Stand Divided We Fall. Amintas S; Bedel A; Moreau-Gaudry F; Boutin J; Buscail L; Merlio JP; Vendrely V; Dabernat S; Buscail E Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290245 [TBL] [Abstract][Full Text] [Related]
60. Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment. Donato C; Szczerba BM; Scheidmann MC; Castro-Giner F; Aceto N J Vis Exp; 2019 May; (147):. PubMed ID: 31157780 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]